openPR Logo
Press release

Investors who lost money with shares of CVRx, Inc. (NASDAQ: CVRX) should contact the Shareholders Foundation in connection with Investigation

An investigation for investors in CVRx, Inc. (NASDAQ: CVRX) shares over potential securities laws violations by CVRx, Inc.

An investigation for investors in CVRx, Inc. (NASDAQ: CVRX) shares over potential securities laws violations by CVRx, Inc.

An investigation was announced for investors of CVRx, Inc. (NASDAQ: CVRX) shares over potential securities laws violations by CVRx, Inc.

Investors who purchased shares of CVRx, Inc. (NASDAQ: CVRX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by CVRx, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Minneapolis, MN based CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.

CVRx, Inc. reported that its annual Total Revenue rose from $22.46 million in 2022 to $39.29 million in 2023, and that its Net Loss declined from $41.42 million in 2022 to $41.19 million in 2023.

On April 30, 2024, after the closure of the market, CVRx, Inc. announced its financial and operating results for the first quarter of 2024.

Shares of CVRx, Inc. (NASDAQ: CVRX) declined from $33.05 per share in December 29, 2023, to $7.77 per share on May 01, 2024.

Those who purchased shares of CVRx, Inc. (NASDAQ: CVRX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investors who lost money with shares of CVRx, Inc. (NASDAQ: CVRX) should contact the Shareholders Foundation in connection with Investigation here

News-ID: 3486219 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for CVRx

Electrical Stimulation Blood Pressure Treatment Devices Market Set To Explode Gr …
The latest Electrical Stimulation Blood Pressure Treatment Devices Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The Industry compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest
Global Neurostimulation Market SWOT Analysis, Key Indicators, Forecast 2027 : Cy …
Neurostimulation Market The market research report titled " Neurostimulation Market Therapies (Spinal Cord, Sacral Nerve, Transcranial Magnetic, TENS, Deep Brain, and Vagus Nerve & Gastric), Application (Epilepsy, Urinary & Fecal Incontinence, Dystonia, Parkinson’s Disease, Pain Management, Essential Tremor, Depression, Gastroparesis, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026 " published by Zion Market Research provides an insightful comprehension about the growth aspects, dynamics, and working of the
Hypertension Management Devices Market 2020 Size, Growth, Opportunity and Foreca …
New York, March 3, 2020: The scope of the report includes a detailed study of Hypertension Management Devices Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Medtronic, Inc, Boston Scientific, Cordis, St. Jude Medical,
Hypertension Management Devices Market 2020 Global Trends Analysis || Leading Pl …
Hypertension management devices market is expected to account to USD 8.26 billion by 2027 expanding at a rate of 17.20% in the forecast period of 2020 to 2027. Rising volume of patients suffering from hypertension associated disorders amid unmet clinical needs of these patients is expected to enhance the potential for growth of the market. Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hypertension-management-devices-market The major players covered in the report are
Hypertension Management Devices Market 2020 : The dynamics of Global Developed & …
Data Bridge Market research has recently released expansive research titled “Global Hypertension Management Devices Market 2020” guarantees you will remain better informed than your competition. In this global business document, market overview is given in terms of drivers, restraints, opportunities and challenges where each of this parameter is studied scrupulously. Get Exclusive sample copy or PDF with (Market Segments, Forecast, Key player’s and TOC) @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-hypertension-management-devices-market&raksh Market Analysis and Insights: Global Hypertension Management Devices Market Hypertension management devices
Hypertension Management Devices Market 2018–2025 | Study Of Key Players Like M …
UpMarketResearch published an exclusive report on “Hypertension Management Devices Market Analysis & Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 97 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Glycidyl Methacrylate market, especially in North America, Europe and Asia-Pacific, South America, Middle